Project

R&D

PROJECT

AAVATAR Therapeutics is advancing a gene therapy platform aimed at addressing globally recognized rare diseases. Our focus includes enhancing therapeutic functions and efficacy, and engineering AAV vectors with tissue-specific expression.

Leveraging the extensive expertise of our multidisciplinary team, we are committed to developing and researching optimal treatments.

Through collaborations with various organizations, we are developing a gene therapy platform to combat rare diseases. Our initiatives include promoting industrial and economic growth via technology transfer of tissue-specific AAV capsids. Additionally, we aim to enhance public health and quality of life through government policy support and public technology development.

Business name	Task name	Specialized organization	Ministry in charge
Regenerative medicine clinical research foundation establishment project	Next-generation intelligent AAV development and experimental statistics-based gene therapy production process establishment	Korea Health Industry Development Institute	Ministry of Health and Welfare
New research personnel recruitment support project	-	Korea Industrial Technology Promotion Association	Ministry of SMEs and Startups
Bio and medical technology commercialization support project (Seoul-type R&D)	Cochlear outer hair cell specific AAV capsid engineering and gene therapy for hearing loss using it	Seoul Economic Promotion Agency	Seoul Metropolitan Government
Baby Unicorn fostering project	Machine learning-based synthetic AAV and high-efficiency customized AAV process technology	Korea Startup Promotion Agency Technology Guarantee Fund	Ministry of SMEs and Startups
Scale-up Tips	Machine learning-based synthetic AAV carrier development and candidate substance for treatment of rare incurable disease Krabbe disease using gene amplification strategy Derivation	Korea Institute for Technology Information Promotion	Ministry of SMEs and Startups
Global Industrial Technology Cooperation Center Project	Lee Syndrome Disease Model and Gene Therapy Development	Korea Institute for Technology Promotion	Ministry of Trade, Industry and Energy